Accovion expands presence in Europe
21 Dec 2010
Accovion, a German company specialising in managing and
conducting international clinical trials, and supporting projects for
the pharmaceutical, biotechnology and medical device industries, has
established two additional subsidiaries in the Czech Republic and in
Russia.
Ivana Waller, Chief Operating Officer of Accovion, stated: "We
have been conducting clinical research activities for our clients in
the Czech Republic and Russia for some time now. Our new affiliate
offices help strengthen our base, give us better access to the local
clinical research talent and enable us to be even more responsive to
our clients' growing needs.
"We were very pleased to bring on board two experienced Managing
Directors — Dr Jiri Skopek for our Prague office and Dr Nikolay
Odintsov for our Moscow office. I am confident that under their
business leadership and with their clinical research expertise, our
operations in both countries will continue to flourish.”
In 2011, Accovion’s strategic plan includes formalizing
activities in several other European countries by establishing
additional subsidiaries. With its active, well-planned expansion,
Accovion aims to offer its clients a broader spectrum of
country-specific clinical research expertise.